Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study
Title:
Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study
Author:
Guigay, J. Fayette, J. Dillies, A.F. Sire, C. Kerger, J.N. Tennevet, I. Machiels, J.P. Zanetta, S. Pointreau, Y. Bozec Le Moal, L. Henry, S. Schilf, A. Bourhis, J.